TokenPost topic
1 TokenPost story is tagged Recurrent Pericarditis. The newest appear first.
Third-quarter ARCALYST net product revenue was $286 million, up about 58% from a year earlier. Kiniksa expects KPL-387 trial data in the second half of 2027.
Oct 27, 2026, 9:55 PM EDT ยท Business